SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Sims who wrote (1873)12/13/1996 9:38:00 PM
From: maho   of 2281
 
Ive said this one hundred times. Stocks 100%% of the time act on earnings and stability. The fact that the current news looks extremly encouraging, the fact of the matter is if there not selling the drug where are the earnings going to come from? I believe that were on the right track with d.r. h and hopefully the next couple of stewps will be towards getting f.d.a. approval for tewsting in the u.s., once that is done and the results are hopefuuly posotive perhaps they will recieve approval to mkt reticulose in the u.s...If in fact that happens their will come the earnings and there will go the stock price, up wit earnings... Any comments,, Regards...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext